Cargando…

COVID-19 multidisciplinary high dependency unit: the Milan model

COVID-19 is a complex and heterogeneous disease. The pathogenesis and the complications of the disease are not fully elucidated, and increasing evidence shows that SARS-CoV-2 causes a systemic inflammatory disease rather than a pulmonary disease. The management of hospitalized patients in COVID-19 d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aliberti, Stefano, Amati, Francesco, Pappalettera, Maria, Di Pasquale, Marta, D’Adda, Alice, Mantero, Marco, Gramegna, Andrea, Simonetta, Edoardo, Oneta, Anna Maria, Privitera, Emilia, Gori, Andrea, Bozzi, Giorgio, Peyvandi, Flora, Minoia, Francesca, Filocamo, Giovanni, Abbruzzese, Chiara, Vicenzi, Marco, Tagliabue, Paola, Alongi, Salvatore, Blasi, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545383/ https://www.ncbi.nlm.nih.gov/pubmed/33036610 http://dx.doi.org/10.1186/s12931-020-01516-8

Ejemplares similares

Once daily aerosolised tobramycin in adult patients with cystic fibrosis in the management of Pseudomonas aeruginosa chronic infection
por: Mantero, Marco, et al.
Publicado: (2017)

Efficacy of Pirfenidone and Nintedanib in Interstitial Lung Diseases Other than Idiopathic Pulmonary Fibrosis: A Systematic Review
por: Amati, Francesco, et al.
Publicado: (2023)

T2-High Endotype and Response to Biological Treatments in Patients with Bronchiectasis
por: Oriano, Martina, et al.
Publicado: (2021)

Identify Drug-Resistant Pathogens in Patients with Community-Acquired Pneumonia
por: Amati, Francesco, et al.
Publicado: (2023)

The biology of pulmonary exacerbations in bronchiectasis
por: Amati, Francesco, et al.
Publicado: (2019)

Nontuberculous mycobacteria infection and pulmonary disease in bronchiectasis
por: Suska, Kseniia, et al.
Publicado: (2022)

Protease–Antiprotease Imbalance in Bronchiectasis
por: Oriano, Martina, et al.
Publicado: (2021)

Lung Microbiome in Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases
por: Amati, Francesco, et al.
Publicado: (2022)

Comparison of different sets of immunological tests to identify treatable immunodeficiencies in adult bronchiectasis patients
por: Aliberti, Stefano, et al.
Publicado: (2022)

Walking the path of treatable traits in interstitial lung diseases
por: Amati, Francesco, et al.
Publicado: (2023)

Efficacy and effectiveness of Ceftaroline Fosamil in patients with pneumonia: a systematic review and meta-analysis
por: Sotgiu, Giovanni, et al.
Publicado: (2018)

Innate and Adaptive Lymphocytes in Non-Tuberculous Mycobacteria Lung Disease: A Review
por: Gramegna, Andrea, et al.
Publicado: (2022)

SARS-CoV-2 vaccines: A critical perspective through efficacy data and barriers to herd immunity
por: Blasi, Francesco, et al.
Publicado: (2021)

Mixed community-acquired lower respiratory tract infections
por: Tarsia, Paolo, et al.
Publicado: (2007)

Genetic and Serum Screening for Alpha-1-Antitrypsin Deficiency in Adult Patients with Cystic Fibrosis: A Single-Center Experience
por: Amati, Francesco, et al.
Publicado: (2022)

Management of Acute Respiratory Failure Due to Community-Acquired Pneumonia: A Systematic Review
por: Vanoni, Nicolò Maria, et al.
Publicado: (2019)

Comparison between the first and second COVID-19 waves in Internal Medicine wards in Milan, Italy: a retrospective observational study
por: Blanca, Deborah, et al.
Publicado: (2022)

Use of anakinra in severe COVID-19: A case report
por: Filocamo, Giovanni, et al.
Publicado: (2020)

Neutrophil elastase in bronchiectasis
por: Gramegna, Andrea, et al.
Publicado: (2017)

Non-Intensive Care Unit Acquired Pneumonia: A New Clinical Entity?
por: Di Pasquale, Marta, et al.
Publicado: (2016)

Alpha-1 antitrypsin deficiency as a common treatable mechanism in chronic respiratory disorders and for conditions different from pulmonary emphysema? A commentary on the new European Respiratory Society statement
por: Gramegna, Andrea, et al.
Publicado: (2018)

Heterogeneity of weight gain after initiation of Elexacaftor/Tezacaftor/Ivacaftor in people with cystic fibrosis
por: Gramegna, Andrea, et al.
Publicado: (2023)

Prevalence and incidence of bronchiectasis in Italy
por: Aliberti, Stefano, et al.
Publicado: (2020)

Anakinra combined with methylprednisolone in patients with severe COVID-19 pneumonia and hyperinflammation: An observational cohort study
por: Bozzi, Giorgio, et al.
Publicado: (2021)

Role of Streptococcus pneumoniae infection in chronic obstructive pulmonary disease patients in Italy
por: Mantero, Marco, et al.
Publicado: (2017)

Serotypes and antibiotic susceptibility of Streptococcus pneumoniae isolated from hospitalized patients with community-acquired pneumonia in Italy
por: Di Pasquale, Marta, et al.
Publicado: (2017)

Lung Recruitability of COVID-19 Pneumonia in Patients Undergoing Helmet CPAP
por: Amati, Francesco, et al.
Publicado: (2021)

From Ivacaftor to Triple Combination: A Systematic Review of Efficacy and Safety of CFTR Modulators in People with Cystic Fibrosis
por: Gramegna, Andrea, et al.
Publicado: (2020)

Acute exacerbations of COPD: risk factors for failure and relapse
por: Mantero, Marco, et al.
Publicado: (2017)

Nontuberculous mycobacterial infections during cancer therapy with immune checkpoint inhibitors: a systematic review
por: Lombardi, Andrea, et al.
Publicado: (2022)

Pro-resolving and pro-inflammatory fatty acid-derived mediators in sputum of stable state bronchiectasis patients
por: Terranova, Leonardo, et al.
Publicado: (2022)

Response
por: Retucci, Mariangela, et al.
Publicado: (2021)

Comments on “PD-1 Inhibitor for Disseminated Mycobacterium avium Infection in a Person Living With HIV”
por: Lombardi, Andrea, et al.
Publicado: (2023)

Non-tuberculous mycobacteria lung disease due to Mycobacterium chimaera in a 67-year-old man treated with immune checkpoint inhibitors for lung adenocarcinoma: infection due to dysregulated immunity?
por: Azzarà, Cecilia, et al.
Publicado: (2023)

Prone and Lateral Positioning in Spontaneously Breathing Patients With COVID-19 Pneumonia Undergoing Noninvasive Helmet CPAP Treatment
por: Retucci, Mariangela, et al.
Publicado: (2020)

Prognostic parameters of in‐hospital mortality in COVID‐19 patients—An Italian experience
por: Ruscica, Massimiliano, et al.
Publicado: (2021)

Comparison of different conditions for DNA extraction in sputum - a pilot study
por: Oriano, Martina, et al.
Publicado: (2019)

Measles surveillance activities in the Metropolitan Area of Milan during 2017-2018
por: BIANCHI, S., et al.
Publicado: (2019)

Cardiovascular autonomic alterations in hospitalized patients with community-acquired pneumonia
por: Aliberti, Stefano, et al.
Publicado: (2016)

Caplacizumab use for immune thrombotic thrombocytopenic purpura: the Milan thrombotic thrombocytopenic purpura registry
por: Agosti, Pasquale, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rtbk2s5ihf8a4f0nsaac671ncl